180 Life Sciences shares drop 34.94% intraday after announcing potential $5B stock sale and name change to ETHZilla Corporation.

180 Life Sciences Corp. plunged 34.94% intraday, following the company's announcement of a potential $5 billion stock sale agreement, which could significantly dilute existing shares, and a name change to ETHZilla Corporation, along with a Nasdaq ticker change to ETHZ, causing market reassessment. The stock had gained 198.88% over the past five trading days and 226.22% in August, leading to a technical correction.